Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Emphasizes Pathogen ID In Complicated Intra-Abdominal Infection Guidance

Executive Summary

The agency checked another box on the list of guidances anticipated by developers of antibiotic drugs with the Oct. 1 release of a draft guidance on treatments for complicated intra-abdominal infections.

You may also be interested in...



Antibiotic Sponsors Get More Flexibility In Final Antibiotic Guidance

FDA is less prescriptive on a variety of clinical development options, including inclusion and exclusion criteria, dosing, study comparators and safety in final document on antibiotics for complicated intra-abdominal infection.

Antibiotic Resistance Gets Attention Of FDA, Congress

Both FDA and Congress are taking interest in combating antibiotic resistance, but FDA likely has more power to make headway in the near term, even as industry remains somewhat wary of that particular agenda item.

MedImmune Deploys Targeted Antibodies In Battle Against Superbugs

Using the ICAAC annual meeting as a platform, MedImmune execs explain efforts to reinvigorate the company’s infectious disease pipeline. Early data suggest a possible supporting role for monoclonal antibody candidates in preventing and treating bacterial infections.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054796

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel